Skip to main content
. 2021 Feb 12;21:81. doi: 10.1186/s12893-021-01074-w

Table 3.

Comparison of intraoperative variables between external stent and internal stent group in high-risk of pancreatic fistula patients

Variables External stent group N = 43 Internal stent group N = 129 P-value
Preoperative biliary drainage 12 (27.9%) 27 (20.9%) P = 0.344
Percutaneous/endoscopic 7/5 7/20
Preoperative total bilirubin (μmol/L) 17.5 (11–135) 28 (13.5–121.5) P = 0.581
Preoperative direct bilirubin (μmol/L) 9.9 (4–107.3) 9.7 (3–79.7) P = 0.535
Preoperative CA 199 (U/mL) 20.7 (5.8–191) 27 (7.9–156.2) P = 0.965
Operative time (min) 492.16 ± 103.63 432.22 ± 136.51 P = 0.003
Intraoperative bleeding (mL) 225 (200–400) 200 (200–400) P = 0.712
  ≤ 400 33 101
  > 400 10 28
 Vascular resection 8 (18.6%) 5 (3.9%) P = 0.004
 Blood transfusion 17 (39.5%) 38 (29.5%) P = 0.220
 Texture soft/Firm 43/0 121/8 P = 0.203
Pancreatic duct diameter (cm) 0.3(0.3–0.4) 0.3 (0.3–0.3) P = 0.205
 0.1 1 0
 0.2 6 26
 0.3 22 76
 0.4 12 22
 0.5 2 4
 > 0.5 0 1
Pathology P = 0.002
Pancreatic adenocarcinoma or pancreatitis 13 14
Ampullary, duodenal, cystic, islet cell, etc 30 115
Pancreatic adenocarcinoma 12 12
Cholangiocarcinoma 2 16
Duodenal carcinoma 16 39
Chronic pancreatitis 1 2
Pancreatic cystic tumor 1 19
Pancreatic neuroendocrine tumor 1 3
Ampullary carcinoma 5 26
Others 5 12

The italic values reflected that there was a significant difference between the two groups